Farrar Daniel, Grocott Mike
Centre for Anaesthesia, University College London, London W1T 3AA.
Hosp Med. 2003 Jun;64(6):352-6. doi: 10.12968/hosp.2003.64.6.352.
Haemoglobin-based oxygen carriers and perfluorocarbons have been developed as artificial oxygen carriers which can be safely administered intravenously. Mixed results from clinical trials to date suggest that further work is required to clearly demonstrate clinical efficacy and safety for these exciting products.
基于血红蛋白的氧载体和全氟化碳已被开发为可安全静脉给药的人工氧载体。迄今为止,临床试验的结果不一,这表明需要进一步开展工作,以明确证明这些令人振奋的产品的临床疗效和安全性。